🔗 Permalink

Inventor profile of:

Daqing Wang

City:

Bedford, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2022-03-24

Top Assignees for applications by Daqing Wang

The entities that hold a legal rights for patent applications filed by inventor Wang Daqing:

IDERA PHARMACEUTICALS, INC. 32 CAMBRIDGE, MA United States
IDERA PHARMACEUTICALS, INC. 5 EXTON, PA United States
Idera Pharamaceuticals, Inc. 1 Cambridge, MA United States

Recent patent applications by Wang Daqing

Daqing Wang from Bedford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-03-24

US20220088054A1

Human necessities

IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT

#2 | 2021-02-25

US20210052625A1

Human necessities

IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT

#3 | 2021-02-11

US20210038630A1

Human necessities

Immune modulation with TLR9 agonists for cancer treatment

#4 | 2020-05-07

US20200138848A1

Human necessities

Immune modulation with TLR9 agonists for cancer treatment

#5 | 2020-04-02

US20200101102A1

Human necessities

TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS

#6 | 2020-02-20

US20200054663A1

Human necessities

Immune modulation with TLR9 agonists for cancer treatment

#7 | 2018-05-10

US20180125877A1

Human necessities

Immune modulation with TLR9 agonists for cancer treatment

#8 | 2018-02-15

US20180044669A1

Chemistry; metallurgy

COMPOSITIONS FOR INHIBITING CHECKPOINT GENE EXPRESSION AND USES THEREOF

#9 | 2018-01-25

US20180023085A1

Chemistry; metallurgy

IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE

#10 | 2017-09-28

US20170274004A1

Human necessities

TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS

#11 | 2017-09-21

US20170268006A1

Chemistry; metallurgy

TOLL-LIKE RECEPTOR 9 ANTAGONIST AND METHODS OF USE THEREOF

#12 | 2017-08-17

US20170233741A1

Chemistry; metallurgy

IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE

#13 | 2017-05-25

US20170145417A1

Chemistry; metallurgy

IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE

#14 | 2016-10-27

US20160312225A1

Chemistry; metallurgy

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#15 | 2016-09-01

US20160251652A1

Chemistry; metallurgy

Compositions for inhibiting checkpoint gene expression and uses thereof

#16 | 2016-08-18

US20160237437A1

Chemistry; metallurgy

Toll-like receptor 9 antagonist and methods of use thereof

#17 | 2016-07-28

US20160215287A1

Chemistry; metallurgy

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#18 | 2016-07-14

US20160201060A1

Chemistry; metallurgy

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#19 | 2016-05-19

US20160138022A1

Chemistry; metallurgy

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#20 | 2016-04-14

US20160101128A1

Human necessities

TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS

#21 | 2014-10-16

US20140308300A1

Chemistry; metallurgy

Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8

#22 | 2014-07-10

US20140193396A1

Chemistry; metallurgy

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#23 | 2013-08-08

US20130202584A1

Human necessities

Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8

#24 | 2013-04-30

US12869209

Compositions for inhibiting gene expression and uses thereof

#25 | 2012-07-19

US20120183530A1

Human necessities

Stabilized immune modulatory RNA (SIMRA) compounds

#26 | 2012-05-24

US20120128699A1

Chemistry; metallurgy

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#27 | 2012-05-03

US20120107303A1

Human necessities

SYNERGISTIC TREATMENT OF CANCER USING IMMUNOMERS IN CONJUNCTION WITH CHEMOTHERAPEUTIC AGENTS

#28 | 2012-01-19

US20120016004A1

Chemistry; metallurgy

COMPOSITIONS FOR INHIBITING GENE EXPRESSION AND USES THEREOF

#29 | 2011-12-22

US20110311518A1

Human necessities

Synthetic agonists of TLR9

#30 | 2011-12-01

US20110293565A1

Chemistry; metallurgy

NOVEL SYNTHETIC AGONISTS OF TLR9

#31 | 2011-06-09

US20110135669A1

Chemistry; metallurgy

SYNTHETIC AGONISTS OF TLR9

#32 | 2011-05-26

US20110123540A1

Human necessities

POTENT MUCOSAL IMMUNE RESPONSE INDUCED BY MODIFIED IMMUNOMODULATORY OLIGONUCLEOTIDES

#33 | 2011-04-07

US20110082186A1

Chemistry; metallurgy

COMPOSITIONS FOR INHIBITING GENE EXPRESSION AND USES THEREOF

#34 | 2011-01-13

US20110009477A1

Human necessities

OLIGONUCLEOTIDE-BASED COMPOUNDS AS INHIBITORS OF TOLL-LIKE RECEPTORS

#35 | 2010-08-26

US20100215642A1

Chemistry; metallurgy

Synthetic RNA-based agonists of TLR7

#36 | 2010-05-06

US20100111937A1

Human necessities

Modulation of toll-like receptor 5 expression by antisense oligonucleotides

#37 | 2010-05-06

US20100111936A1

Chemistry; metallurgy

Modulation of Toll-Like Receptor 4 Expression by Antisense Oligonucleotides

#38 | 2010-05-06

US20100111935A1

Chemistry; metallurgy

Modulation of Toll-Like Receptor 2 Expression By Antisense Oligonucleotides

#39 | 2010-04-15

US20100092486A1

Chemistry; metallurgy

MODULATION OF MYELOID DIFFERENTATION PRIMARY RESPONSE GENE 88 (MYD88) EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES

#40 | 2010-02-25

US20100047188A1

Human necessities

MODULATION OF TOLL-LIKE RECEPTOR 8 EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES

#41 | 2010-02-18

US20100041735A1

Human necessities

Modulation of toll-like receptor 3 expression by antisense oligonucleotides

#42 | 2010-02-18

US20100041734A1

Human necessities

MODULATION OF TOLL-LIKE RECEPTOR 7 EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES

#43 | 2010-02-11

US20100035967A1

Chemistry; metallurgy

MODULATION OF TOLL-LIKE RECEPTOR 9 EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES

#44 | 2009-04-16

US20090098063A1

Human necessities

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#45 | 2009-04-02

US20090087388A1

Human necessities

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#46 | 2009-03-26

US20090081198A1

Human necessities

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#47 | 2009-03-05

US20090060898A1

Chemistry; metallurgy

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#48 | 2009-02-26

US20090053206A1

Human necessities

Synthetic agonists of TLR9

#49 | 2009-02-26

US20090053205A1

Human necessities

Stabilized immune modulatory RNA (SIMRA) compounds

#50 | 2009-02-26

US20090053148A1

Human necessities

Toll like receptor modulators

#51 | 2008-11-27

US20080292648A1

Chemistry; metallurgy

Synthetic agonists of TLR9

#52 | 2008-08-28

US20080206265A1

Human necessities

Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents

#53 | 2008-07-17

US20080171712A1

Chemistry; metallurgy

Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8

#54 | 2008-04-17

US20080089883A1

Human necessities

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#55 | 2005-10-06

US20050222072A1

Human necessities

Potent mucosal immune response induced by modified immunomodulatory oligonucleotides

#56 | 2005-01-13

US20050009773A1

Human necessities

Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents

InventorID:

376299 ⎘